Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) Fell 1.41% to 14.020
Newtimespace News, as of 09:44 on May 15, Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) was quoted at HKD 14.020, down 1.41%. The ETF opened at HKD 14.220, with a high of HKD 14.230 and a low of HKD 14.000. The latest Net Asset Value (NAV) per unit is HKD 14.283, with a premium rate of -0.44%. The asset size is approximately HKD 2.217 billion.
Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) tracks the Hang Seng Biotech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index tracks the 30 largest biotechnology companies eligible for Southbound Stock Connect trading, aiming to reflect the overall performance of biotech companies listed in Hong Kong. The industry coverage includes core areas such as pharmaceuticals, biotechnology, pharmaceutical distribution, and medical equipment.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- DETAI NEWENERGY (00559.HK): Enters Memorandum of Understanding for Proposed Acquisition of HKD 505 Million; Trading Remains Suspended
- SCIENTECH (02291.HK): Acquires 54.2384% Equity of Shanghai Minwei Biotechnology for RMB 1.088 Billion, Constituting Major and Connected Transaction
- CHINAHONGQIAO (01378.HK): Revises Annual Caps under Industrial Products Purchase Agreement, 2027 Cap Raised to RMB 26.24 Million